Category: News

One of our major 2025 Q3 milestones is the addition of Dimethyltryptamine (DMT) to our Health Canada Dealer’s License. DMT is a naturally occurring psychedelic compound that has gained significant attention in recent years for its potential therapeutic applications. Once known primarily for its role in traditional Amazonian medicine and its powerful hallucinogenic effects, DMT … Continued

April 15, 2025 — Sunshine Labs, a leading innovator in medical technologies for Substance Use Disorder (SUD), is pleased to announce an exclusive global distribution agreement (excluding the United States) with Sperenza Therapeutics for its flagship device, S.T. Genesis™, with its wholly owned subsidiary, Waxed International. This agreement with Speranza Therapeutics grants Waxed International exclusive … Continued

Current Research on Evidence-Based Solutions  As Canada and the rest of the world continue to grapple with a massive public health crisis driven by toxic, unregulated drugs, a growing body of new evidence is reshaping the response. Prescribed alternatives-commonly known as “safer supply”– are an effective, evidence-based strategy to reduce overdose deaths and improve the … Continued

Advancing Pharmaceutical Innovation with Compliance and Safety We are thrilled to announce a major milestone in our journey: the approval of our first import license for a highly specialized raw material. This marks a significant step forward in our mission to support the pharmaceutical industry with safe, compliant, and high-quality products. About The Product The … Continued